This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: hypertension

August 2017 Br J Cardiol 2017;24:95–6

General news

BJCardio Staff

Abstract

Improvements in patient care mean hundreds more people are surviving heart failure, a new independent study has found. The latest report from the National Heart Failure Audit (April 2015– March 2016) (link below) has found that the mortality rate for people admitted to hospital with heart failure has dropped from 9.6% the previous year to 8.9%. The reduction in the mortality rate means that in the region of 500 lives have been saved in the past year compared to 2014–15. An assessment of patients admitted to hospital with heart failure at NHS Trusts also shows that more people are being provided with crucial medicines for heart disease as

| Full text

June 2017 Br J Cardiol 2017;24:61

In brief

BJCardio Staff

Abstract

Nanoparticles, inhaled from sources such as vehicle exhausts, have been shown to cross from the lungs into the blood stream. They can then accumulate in areas susceptible to heart problems, according to research part-funded by the British Heart Foundation.  Previous studies have identified a correlation but not a causal link between nanoparticles and strokes or cardiovascular disease. It is not currently possible to measure environmental nanoparticles in the blood. So, researchers from the University of Edinburgh, and the National Institute for Public Health and the Environment in the Netherlands, used a variety of specialist techniques to t

| Full text

March 2017 Br J Cardiol 2017;24:11–12 doi:10.5837/bjc.2017.005

Optimising BP measurement and treatment before elective surgery: taking the pressure off

Simon G Anderson, Nigel Beckett, Adam C Pichel, Terry McCormack

Abstract

This publication in the British Journal of Cardiology is part of the need for coordinated publications to ensure that cardiologists are aware of the current consensus. The recommendations are limited to a specific scope – the period prior to planned surgery. Blood pressures that may cause an immediate risk to health are specified, rather than those that may cause risk over the long term. The best method of taking accurate blood pressure measurements is also examined. For the cardiologist who may be contacted to provide advice and management options for hospitalised patients with elevated blood pressure during the pre-operative period, this

| Full text
Book review: Hypertension, 2nd edition

March 2016 Br J Cardiol 2016;23:15

Book review: Hypertension, 2nd edition

Terry McCormack

Abstract

Publisher: Oxford Cardiology Library, Oxford University Press, Oxford, 2015 ISBN: 9780198701972 Price: £19.99 I have always been fascinated by how primary care and secondary care look at hypertension in different lights. This pocket reference, written by cardiologists, demonstrates those differences and will mainly be of interest to their specialist colleagues. Examples of this are the inclusion of echocardiograms as basic investigations, whilst home blood pressure monitoring is never mentioned. Mostly written by Sunil Nadar, it is a collection of chapters that often repeat statements from previous chapters, particularly involving the epidem

| Full text
Statins and myalgia: fact or fiction?

October 2015 Br J Cardiol 2015;22:127–9 doi:10.5837/bjc.2015.033

Statins and myalgia: fact or fiction?

Peter Sever

Abstract

(more…)

| Full text
Coenzyme Q10 and cardiovascular disease: an overview

October 2015 Br J Cardiol 2015;22:160 doi:10.5837/bjc.2015.037

Coenzyme Q10 and cardiovascular disease: an overview

David Mantle

Abstract

(more…)

| Full text

October 2015 Br J Cardiol 2015;22:138–142

News from the European Society of Cardiology Congress 2015

BJCardio Staff

Abstract

(more…)

| Full text
Hypertension, LVH, echo…and stuff

June 2015 Br J Cardiol 2015;22:65–6

Hypertension, LVH, echo…and stuff

Heather Wetherell

Abstract

A 56-year-old woman attends for a well-woman blood pressure (BP) check. After three repeated measurements, a minute apart, her mean BP is 146/90 mmHg so the practice nurse decides to do an electrocardiogram (ECG), in accordance with the practice protocol. Figure 1 shows the ECG obtained. Figure 1. The electrocardiogram obtained during the well-woman check What is your impression? Does she need any further investigations? Discussion The main purpose of showing this ECG is to discuss the various voltage criteria for left ventricular hypertrophy (LVH). Interestingly, there is no one universally agreed criteria for diagnosis of LVH by ECG.  A fe

| Full text

June 2014 Br J Cardiol 2014;21:51

Correspondence: aggressive risk factor modification: 30 year follow-up of IHD and non-haemorrhagic stroke

John Revill

Abstract

Aggressive risk factor modification: 30 year follow-up of IHD and non-haemorrhagic stroke Dear Sirs, In a single doctor’s practice in a high-risk area of South Sheffield, aggressive measures were taken to prevent ischaemic heart disease (IHD) and non-haemorrhagic stroke (ST) since 1980. Four cardinal risk factors were detected: smoking, diabetes, hypertension and cholesterol. Smoking, diabetes and hypertension were treated critically using standard guidelines and applying the latest evidence available independent of cost from 1980 onwards. Mortality from IHD has been known for many years to be directly related to the level of serum choleste

| Full text
News from ACC.14

April 2014 Br J Cardiol 2014;21:56–7 Online First

News from ACC.14

BJCardio Staff

Abstract

HEAT-PPCI: heparin outperforms bivalirudin in primary PCI The major talking point of this year’s American College of Cardiology meeting was without doubt the aptly named HEAT-PPCI trial which generated more heat than has been seen at such conferences for quite some time. The trial acronym stands for How Effective Are Antithrombotic Therapies in Primary PCI (percutaneous coronary intervention), and the study – conducted in the UK under the leadership of Dr Rod Stables (Liverpool Heart and Chest Hospital) – compared unfractionated heparin with bivalirudin (Angiomax®, the Medicines Company) in patients with ST-elevation myoca

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now